INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Grant or awardVerified data

Zuraw Qing Che reported VOR

Chief Development Officer · Vor Biopharma Inc. · Vor Biopharma Inc. — Employee Stock Option (right to buy)

Side
A
Value
—
Shares
218.7K
Price
—
Executed
Dec 5, 2025
Disclosed
Dec 9, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 5 executedDec 9, 2025 disclosed

VOR · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · VOR

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    LD
    Levin Andrew DavidDirector
    VORVor Biopharma Inc.
    Grant or award
    		A—
    3,000 sh
    		Dec 18, 2025Dec 19, 2025
    traded Dec 18, 2025
    		+1dSEC FORM 4

    Evidence

    9
    JW
    Joustra WouterDirector
    VORVor Biopharma Inc.
    Grant or award
    		A—
    3,000 sh
    		Dec 18, 2025Dec 19, 2025
    traded Dec 18, 2025
    		+1dSEC FORM 4

    Evidence

    9
    ZC
    Zuraw Qing CheChief Development Officer
    VORVor Biopharma Inc.
    Disposition to issuer
    		D—
    218.7K sh
    		Dec 5, 2025Dec 9, 2025
    traded Dec 5, 2025
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002079210-25-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 5, 2025
    Published
    Dec 9, 2025
    Ingested by INSIDER
    Nov 5, 04:28 UTC
    Last re-read
    Nov 5, 04:28 UTC

    Extracted facts

    Filer
    Zuraw Qing Che
    Role
    Chief Development Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Vor Biopharma Inc. — Employee Stock Option (right to buy)
    Ticker
    VOR
    Shares
    218.7K
    Price per share
    $0
    Execution date (reported)
    Dec 5, 2025
    Owned after transaction
    218.7K shares
    Days from execution to publication
    4

    What this establishes

    Zuraw Qing Che filed this Form 4 reporting a grant or award of VOR on Dec 5, 2025. It became public on Dec 9, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Development Officer
    Zuraw Qing Checik:0002079210
    Issuer
    Vor Biopharma Inc.cik:0001817229

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.